RBC Capital lowered the firm’s price target on Visteon (VC) to $127 from $140 and keeps an Outperform rating on the shares. The company’s FY26 adjusted EBITDA guidance came in well below consensus expectations, largely driven by one-offs and lower revenues y/y, the analyst tells investors in a research note. RBC adds however that the estimated headwind from BMS sales could be overstated.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on VC:
